Usana Health Sciences Inc (USNA) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

USNA ranks #3865 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

USNA is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

139 institutions disclose a position in USNA, but none treat it as a major bet — even Nantahala Capital Management, LLC, its most concentrated holder, allocates just 0.6% of its own portfolio to it.

State of Alaska, Department of Revenue has added to its USNA position for two straight quarters, increasing it by $57.0K to reach $172.0K today.

Assenagon Asset Management S.A. has trimmed its USNA position for two straight quarters, cutting it by $1.1M while still holding $552.9K.

USNA is up 3.1% today, and institutions have been net buyers of $35.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

USNA reported a net loss of $22.2M over the trailing twelve months.

• Not yet profitable — net loss of $22.2M over the trailing twelve months
• Revenue grew 1.6% year over year
• Net income declined year over year, from $34.1M to -$22.2M
• Generated $22.3M in positive operating cash flow
• Current ratio of 2.24x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.29x equity — within a conventional range